Giving the Gift of Discovery this Holiday Season

It is officially gift giving season in the United States, and across the country people will be on the receiving end of gestures that could change their lives.

One item that could spawn a lifetime of memories and adventure is a Garrett metal detector. Company marketing director Steve Moore has seen firsthand how these gifts can influence a new explorer.

“That’s what I love. When you see a young person, a child, pick up one of these metal detectors and they go out and they find their first coin or a neat relic or maybe a piece of jewelry,” he said. “Once they find something really good, I mean they are hooked. And you probably can’t get them to put that thing down after that.”

Whether someone receives a Garrett metal detector this season or not, they very well may come into contact with one during the holidays in a different capacity than treasure hunting. The security division of the company equips airports, schools and event venues with wands and walk-through detectors to keep the public safe.

“When you see that security product that keeps you safe at your schools or at your sporting event, remember that’s also the same company that brings you fun and outdoor excitement with these treasure hunting models,” Moore said.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More